Clinical Trials Logo

Clinical Trial Summary

Intensive care unit (ICU) patients commonly display hyperglycemia, even without previously known diabetes. It was demonstrated that hyperglycemia was associated with increased hospital mortality in various medical and surgical ICU situations. However, discrepant results from recent randomized, clinical trials of tight blood glucose control in ICUs have not allowed conclusions regarding whether there is a causal link between hyperglycemia and ICU mortality. In addition to the mean blood glucose level, glucose variability has recently been emphasized as an independent predictor of ICU and hospital mortality. This concept has been described in a wide variety of medical, surgical and trauma ICU patients. In all of these settings, glycemic variability was measured with various indices but was steadily associated with ICU and/or hospital mortality in non-diabetic ICU patients. Conversely, glycemic variability was either weakly or not associated with mortality in ICU patients with previously known diabetes. Notably, all of these data have been observational, and interventional trials remain lacking to assess the impact of glycemic variability reduction on ICU mortality and thus to demonstrate causality. However, glycemic variability was considered sufficiently important to be mentioned in recent international guidelines for the management of hyperglycemia in critically ill patients. In these publications, experts from the American College of Critical Care Medicine emphasized that glycemia should be maintained at less than 9.9 mmol/L in ICU patients while avoiding hypoglycemia and minimizing glycemic variability. To achieve these goals, computer-based insulin infusion protocols have demonstrated their superiority to paper-based protocols. Glucose concentrations, variation per unit of time between the last and current glucose measurements, insulin dosage, and carbohydrate intake were the main input variables used in these different computerized algorithms. However, such protocols are not widely available because commercial systems have licensing fees and academic protocols do not always go beyond the pilot phase.

To address this issue, the investigators adapted a previously validated, paper-based, dynamic protocol (DP) to an actual recommended glycemic target range. Our aim was to assess the efficacy, safety, feasibility and acceptance by nurses of this dynamic insulin protocol, compared to a paper-based, sliding scale static protocol (SP).


Clinical Trial Description

n/a


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02847104
Study type Observational
Source University Hospital, Caen
Contact
Status Completed
Phase N/A
Start date February 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02946411 - Correlation of Hospital Stay Length With the Glucose Levels After Cardiac Surgery
Completed NCT04408768 - Stress Hyperglycemia and Acute Ischemic Stroke
Terminated NCT03743025 - Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients Phase 4
Completed NCT02726958 - Early Postoperative Blood Glucose Variability and Outcome After TAVI N/A
Not yet recruiting NCT05314725 - Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial Phase 2
Completed NCT01969149 - Exenatide for Stress Hyperglycemia Phase 2/Phase 3
Terminated NCT02068989 - Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus N/A
Not yet recruiting NCT01776476 - A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma Phase 2
Recruiting NCT02180555 - Diabetes Mellitus After Intensive Care Admission N/A
Not yet recruiting NCT04591561 - Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital